Back
Apellis Pharmaceuticals Stock Price Chart
Sponsored
APLS
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
APLS
Apellis Pharmaceuticals
Last Price:
$33.17
Seasonality Move:
10.43%
7 Day Trial
ALL ACCESS PASS
$
7
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
Apellis Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.79 | Sell |
20-day SMA: | 33.49 | Sell |
50-day SMA: | 30.76 | Buy |
200-day SMA: | 38.45 | Sell |
8-day EMA: | 32.69 | Sell |
20-day EMA: | 32.77 | Sell |
50-day EMA: | 32.1 | Sell |
200-day EMA: | 38.14 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 45.92 | Sell |
Chaikin Money Flow: | -261139 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.58 - 34.44) | Sell |
Bollinger Bands (100): | (28.14 - 36.94) | Sell |
Apellis Pharmaceuticals Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 31.91 while APLS 8-day simple moving average is 32.79, which is a Sell signal.
-
The stock price of APLS is 31.91 while Apellis Pharmaceuticals 20-day SMA is 33.49, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 30.76 while APLS share price is 31.91, making it a Buy technically.
-
APLS stock price is 31.91 and Apellis Pharmaceuticals 200-day simple moving average is 38.45, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
39
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $31.91. The Score for APLS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
4.1B
Price in USD:
31.91
Share Volume:
977.4K
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
24.34
Sell
39
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 31.91 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 31.91 while APLS 8-day exponential moving average is 32.69, which is a Sell signal.
-
The stock price of APLS is 31.91 while Apellis Pharmaceuticals 20-day EMA is 32.77, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day exponential moving average is 32.10 while APLS share price is 31.91, making it a Sell technically.
-
APLS stock price is 31.91 and Apellis Pharmaceuticals 200-day simple moving average is 38.14, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $2.02 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Apellis Pharmaceuticals is a Buy
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 45.92, which suggest Apellis Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (32.58 - 34.44), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (28.14 - 36.94), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.